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Abstract
Objective: Obesity, represented by high body mass index (BMI), is a major complication after treatment for childhood
cancer. However, it has been shown that high total fat percentage and low lean body mass are more reliable predictors of
cardiovascular morbidity. In this study longitudinal changes of BMI and body composition, as well as the value of BMI and
waist-hip ratio representing obesity, were evaluated in adult childhood cancer survivors.
Methods: Data from 410 survivors who had visited the late effects clinic twice were analyzed. Median follow-up time was
16 years (interquartile range 11–21) and time between visits was 3.2 years (2.9–3.6). BMI was measured and body
composition was assessed by dual X-ray absorptiometry (DXA, Lunar Prodigy; available twice in 182 survivors). Data were
compared with healthy Dutch references and calculated as standard deviation scores (SDS). BMI, waist-hip ratio and total fat
percentage were evaluated cross-sectionally in 422 survivors, in who at least one DXA scan was assessed.
Results: BMI was significantly higher in women, without significant change over time. In men BMI changed significantly with
time (DSDS= 0.19, P,0.001). Percentage fat was significantly higher than references in all survivors, with the highest SDS
after cranial radiotherapy (CRT) (mean SDS 1.73 in men, 1.48 in women, P,0.001). Only in men, increase in total fat
percentage was significantly higher than references (DSDS = 0.22, P,0.001). Using total fat percentage as the gold standard,
65% of female and 42% of male survivors were misclassified as non-obese using BMI. Misclassification of obesity using waist-
hip ratio was 40% in women and 24% in men.
Conclusions: Sixteen years after treatment for childhood cancer, the increase in BMI and total fat percentage was
significantly greater than expected, especially after CRT. This is important as we could show that obesity was grossly
underestimated using BMI and waist-hip ratio.
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Introduction
Childhood cancer survival rates have increased enormously
over the last few decades [1,2]. As a consequence, the incidence of
treatment related complications is increasing. One of the major
sequelae is obesity, with a prevalence of 9 to 30% depending on
former treatment modalities [3,4,5]. Body mass index (BMI) is the
most widely used measure for obesity. However, it has been shown
that a high amount of total body fat, high intra-abdominal fat
percentage and low lean body mass are more reliable determinants
than high BMI in predicting the development of cardiovascular
disease or diabetes mellitus [6,7,8,9,10]. In a recent study, Shah
and Braverman showed that BMI misclassified 48% of the female
and 25% of the male population using total fat percentage
measured by dual X-ray absorptiometry (DXA) as the gold
standard. This lead to an underestimation of the prevalence of
obesity [10]. Waist circumference, which approximates the
amount of intra-abdominal fat, is a more accurate marker than
BMI and is one of the criteria used to define metabolic syndrome
[11,12].
In childhood cancer survivors, abnormal body composition has
been thoroughly described and is caused by several factors
including damage to the hypothalamus and/or pituitary due to
cranial radiotherapy and use of corticosteroids [5,11,12,13,14,15].
Most studies that investigated changes in body composition, in
addition to BMI, were cross-sectional and included small cohorts
and selected subgroups, such as acute lymphoblastic leukemia
(ALL) survivors [11,16,17,18]. Currently, long-term survivor
studies measuring body composition longitudinally are not
available. The Childhood Cancer Survivor Study has reported
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changes in BMI with a very long-term follow-up of 25 years [19].
The aim of our study was to investigate longitudinal changes in
BMI and body composition, and to evaluate the value of BMI and
waist-hip ratio as compared with total fat percentage measured by
DXA in long-term adult childhood cancer survivors in a single
center in the Netherlands.
Subjects and Methods
Ethics Statement
The data described in the current retrospective study were
obtained during regular visits at the late effects clinic, and clinical
investigations were assessed using the standard guidelines for
screening late effects after childhood cancer following Good
Clinical Practice (GCP). An official written informed consent from
every patient that visited the outpatient clinic was obtained
according to standards of the Institutional Review Board (IRB).
Subjects
We performed a retrospective single center study. Follow-up of
subjects at our late effects outpatient clinic for long-term childhood
cancer survivors starts 5 years after cessation of therapy and is
individualized based on cancer diagnosis and treatment protocol.
Out of 909 adult childhood cancer survivors diagnosed and
treated between 1964 and 2005, 610 had visited the outpatient
clinic and 410 had visited the outpatient clinic twice (figure 1).
Longitudinal changes in BMI were evaluated in survivors with 2
visits. Cross-sectional evaluation of BMI, waist-hip ratio and total
fat percentage was assessed in 423 survivors. One survivor was
diagnosed with Down syndrome and was therefore excluded.
Methods
Treatment details, as well as disease and patient characteristics,
were retrieved from our local database (table 1). Information
regarding pituitary dysfunction and hormone supplementation
were evaluated. Body mass index (BMI) was calculated from
height and weight [20]. Waist-hip ratio was calculated from waist
and hip circumference [21]. Lean body mass and total fat
percentages were measured by DXA using a single machine
(DXA, Lunar Prodigy, GE Healthcare, Madison, WI, USA). Data
from sequential DXA scans was available in 182 survivors. Obesity
was defined as BMI $30 [22], total fat percentage $25% (M) and
$30% (W) [23] and waist-hip ratio $0.85 (W) and $0.90 (M)
[21].
Final height data were compared with Dutch adult references
described by Fredriks et al. [24]. BMI data were compared with
data from self-reported questionnaires, which are sent out yearly to
10 000 subjects by the central office for statistics (CBS) in the
Netherlands [25]. Lean body mass and total fat percentage data
were compared with healthy Dutch references [26,27]. To adjust
for age and gender, standard deviation scores were calculated for
final height, BMI and body composition measures.
Growth hormone deficiency (GHD) was defined by an
insufficient growth hormone stimulation test (growth hormone
peak ,3 mg/L during an insulin tolerance test or ,9 mg/L during
a GHRH-Arginine test [28]). Hypothyroidism was defined as an
fT4 level ,11 pmol/L in combination with normal or high TSH
levels (.4.3 mU/L; primary hypothyroidism) or a TSH level
,0.4 mU/L (secondary hypothyroidism). Hypogonadism was
defined as a testosterone level ,9 nmol/L in men or oligo/
amenorrhea in women.
Laboratory Measurements
Serum insulin-like growth factor-I (IGF-I; nmol/L) was
measured using a chemi-luminescence-based immunoassay (Im-
mulite 2000, Siemens DPC, Los Angeles CA, USA). Intra- and
interassay coefficients of variation (CV) were ,5 and ,7%. IGF-I
levels were compared with reference values by using standard
deviation scores (SDS) [29]. In cases where GHD was suspected
(i.e. IGF-I below 22 SDS) a growth hormone stimulation test was
assessed. Testosterone (nmol/l) was measured by coated tube
radioimmuno-assay (Siemens DPC). Intra- and interassay CVs
were ,6 and ,9% respectively. Thyroid stimulating hormone
(TSH) (U/L) and free thyroxine (fT4) (pmol/l) were measured
using chemoluminescence assays (Vitros ECi Immunodiagnostic
System; Ortho Clinical Diagnostics, Rochester, NY). Interassay
CV was 4.7–5.4% for fT4 and 2.5–4.1% for TSH.
Statistics
To evaluate longitudinal changes in BMI and body composi-
tion, treatment modalities were categorized into five groups:
cranial radiotherapy as defined by central nervous system
irradiation in leukemia/lymphoma survivors (CRT), brain tumor
irradiation directed to the indicated tumor field (BRT), total body
irradiation (TBI), corticosteroids (without irradiation), and other
treatment (neither cranial irradiation nor corticosteroids). Stan-
dard deviation scores were calculated for BMI, total fat percentage
and lean body mass and were compared with healthy references
using the one sample t-test. When analyzing the rough data,
differences between 1st and 2nd assessments were tested using the
paired t-test (figure 2). Growth hormone deficient subjects were
excluded from the analysis because growth hormone treatment
causes a significant decrease of total body fat [30]. Multivariate
regression analysis was performed to determine the influence of
age at diagnosis, hypothyroidism, hypogonadism and use of oral
contraceptives on BMI and measures of body composition.
To evaluate the value of BMI and waist-hip ratio, total fat
percentage, retrieved from DXA scans, was used as the gold
standard. Total fat percentage was compared with BMI and waist-
hip ratio, to determine percent agreement and disagreement,
separately in men and women. A Receiver Operating Curve
(ROC) analysis stratified by sex was used to evaluate sensitivity
and specificity for BMI and waist-hip ratio and to determine more
accurate cut-off points relative to total fat percentage. Survivors
who had been treated with abdominal radiotherapy were excluded
from the waist-hip ratio analysis.
P-values were considered statistically significant if p,0.05.
Statistical analysis was performed using SPSS 17.0 software (SPSS,
Chicago, IL).
Results
Survivors
Baseline and treatment characteristics are shown in Table 1.
Median follow-up time between cessation of therapy and the first
visit at the outpatient late effects clinic was 16 years (interquartile
range (IQR) 11–21). Median time between the 1st assessment
(defined as T1) and 2nd assessment (defined as T2) was 3.2 years
(IQR 2.9–3.6). Forty-five, mainly leukemia survivors, had been
treated with CRT (25 Gy (24–25)), including 3 survivors that had
received craniospinal irradiation; thirty-nine, mainly brain tumor
survivors, had been treated with BRT (40 Gy (35–44)). Two
leukemia survivors had been treated with CRT and TBI and were
analyzed in the CRT group. One brain tumor survivor had
received BRT and TBI and was analyzed in the BRT group. One
hundred and forty-three survivors had been treated with
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corticosteroids but not cranial irradiation, and 170 had only been
treated with chemotherapy, not with corticosteroids or cranial
irradiation.
Fifteen survivors had been diagnosed with GHD earlier and
were treated with growth hormone (GH) therapy at time of follow-
up, and were excluded from further analysis. Hypothyroidism was
present in 14 survivors at T1 and 18 survivors at T2.
Hypogonadism was present in 21 survivors at T1 and 25 survivors
at T2. There were no subjects with untreated hypogonadism and
hypothyroidism. Oral contraceptives were used by 94 women at
T1 and 86 at T2. Multivariate analysis showed that total fat
percentage was not associated with hypogonadism or hypothy-
roidism during adequate replacement therapy, nor with oral
contraceptive use. After correction for height SDS, lean body mass
was significantly associated with hypothyroidism in female
survivors, which were therefore excluded from the analysis (b
21.20, p= 0.039). BMI was significantly associated with hypogo-
nadism in male survivors, which were therefore excluded from the
analysis (b 0.92, p = 0.015). Age at diagnosis was not significantly
associated with BMI and body composition.
Body Mass Index
Male survivors had a significantly lower BMI at T1 (SDS=
20.17, P= 0.022) and showed a significant change over time
(DSDS =0.19, P,0.001). When analyzing treatment groups
separately BMI at T1 was not significantly different from Dutch
references, but changed significantly over time in all groups
except for TBI (figure 2). In female survivors BMI was
significantly higher compared with references, without signifi-
cant change over time (SDS T1= 0.22, P= 0.024, T2=0.25,
P= 0.006). When analyzing treatment groups separately only
cranial irradiated female leukemia/lymphoma survivors had
significantly higher BMI without significant change over time
(SDS T1= 0.41, P= 0.021, T2 0.51, P= 0.031). Both male and
Figure 1. Flowchart of included survivors. FU follow-up; CCS childhood cancer survivors; GHD Growth hormone deficiency.
doi:10.1371/journal.pone.0043269.g001
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Figure 2. Standard deviation scores (SDS) of body mass index, total fat percentage, lean body mass and height in different therapy
groups expressed as mean at T1 and T2. * Significantly higher increase as compared to references (one-paired T-test, p,0.05).
doi:10.1371/journal.pone.0043269.g002
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female TBI survivors had a significantly lower BMI compared
with references (figure 2).
Total Fat Percentage
Fat percentage was significantly higher compared with Dutch
references in both men (SDS T1 1.37, P,0.001) and women
(SDS T1 1.05, P,0.001). The highest fat percentage was found
after CRT (mean SDS T1 1.73 in men, 1.48 in women,
P,0.001) (figure 2). In men, fat percentage increased signifi-
cantly (DSDS=0.22, P,0.001). Evaluating treatment groups
separately, fat percentage increased significantly in all groups
except for the TBI group (figure 2). In female survivors no
significant increase of fat percentage was found (DSDS=0.07,
P=0.22).
Height and Lean Body Mass
Lean body mass, as well as height, were significantly lower in all
treatment groups, compared with Dutch references, except for
female BRT survivors (figure 2). Adjusted for height SDS, lean
body mass SDS was significantly lower in male TBI survivors only
(T1, P=0.01; T2, P=0.004). Lean body mass did not change over
time in either men or women in any of the treatment groups
(figure 2).
BMI and Waist-hip Ratio as Compared with Total Fat
Percentage
Out of 407 survivors 210 (52%) were misclassified as non-
obese based on BMI, while meeting the obesity criteria based
on total fat percentage. In female survivors this percentage of
misclassification was even higher (65%) than in men (42%)
(Table 2, figure 3). Waist-hip ratio was classified as non-obese
and total fat percentage as obese in 92 out of 299 survivors
(31%). This percentage of misclassification was 40% in female
and 24% in male survivors (figure 4). We attempted to define
new cut-off points for BMI and waist-hip ratio to better identify
childhood cancer survivors as obese, using total fat percentage
as the gold standard (table 3). Sensitivity improved by 58%
(from 14% to 72%) in males, with a loss in specificity of only
24% (100% to 76%) using a BMI cut-off of 24 instead of 30. In
females a cut-off of 22 would give an increase in sensitivity of
64% (16 to 80%) with a loss in specificity of only 18% (100%
to 82%). Cut-off points for waist-hip ratio, as defined by the
WHO, were more accurate than BMI in childhood cancer
survivors (table 3), although a cut-off limit of 0.82 instead of
0.85 in women would give an increase in sensitivity of 26%
(45% to 71%), with a loss in specificity of 14% (85% to 71%).
Table 1. Baseline characteristics of survivors included in this study.
Survivors with DXA scan (cross-sectional data) Survivors with two visits (longitudinal data)
Male N=243 Female N=179 Male N=229 Female N=180
Age at diagnosis (yrs) 6.3 (3.4–11.8) 6.5 (3.2–11.7) 6.7 (3.3–11.8) 6.2 (2.9–11.7)
Age at follow-up (yrs) 25.8 (21.9–31.4) 26.6 (22.3–32.7) 23.8 (20.2–28.0) 25.4 (21.0–30.1)
Time between DXA’s (yrs) n.a. n.a. 3.2 (2.9–3.6) 3.1 (2.9–3.4)
Follow-up time (yrs) 17.5 (12.1–23.0) 17.9 (13.2–23.7) 15.9 (11.2–20.3) 17.0 (11.9–22.4)
Diagnosis
ALL, T-NHL 107 (44) 82 (46) 79 (35) 58 (33)
AML 10 (4) 7 (4) 8 (4) 8 (4)
B-NHL 28 (12) 14 (8) 24 (11) 14 (8)
Hodgkin lymphoma 32 (13) 14 (8) 25 (11) 16 (9)
Bone tumor 4 (2) 6 (3) 11 (5) 8 (4)
Wilms tumor 26 (11) 21 (12) 26 (11) 24 (13)
Neuroblastoma 5 (2) 10 (6) 11 (5) 18 (10)
Germ cell tumor 1 (1) 1 (1) 4 (2) 5 (3)
MMT 6 (3) 5 (3) 17 (7) 13 (7)
Brain tumor 15 (6) 9 (5) 15 (7) 7 (4)
Other 17 (7) 16 (9) 9 (4) 9 (5)
Therapy
CRT 43 (18) 28 (16) 26 (11) 19 (11)
BRT 9 (4) 3 (2) 31 (14) 8 (4)
Corticosteroids 124 (51) 88 (49) 75 (33) 68 (38)
No CRT/corticosteroids 54 (22) 50 (28) 91 (40) 79 (44)
TBI 13 (5) 10 (6) 6 (3) 6 (3)
Abdominal RT 15 (6) 14 (8) n.a. n.a.
Data are expressed as median (interquartile range) or as frequencies (N %).
ALL Acute lymphoblastic leukemia; AML Acute myeloid leukemia; B-NHL B-cell non hodgkin lymphoma; T-NHL T-cell non hodgkin lymphoma; MMT Malignant
mesenchymal tumor; CRT Cranial radiotherapy; BRT Local radiotherapy on cranium; TBI Total body irradiation.
doi:10.1371/journal.pone.0043269.t001
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Discussion
Male survivors showed an increase of BMI and total fat
percentage during a median follow-up time of 3.2 years, more
than 15 years after treatment for childhood cancer. Female
survivors, especially the cranial irradiated leukemia/lymphoma
subgroup, showed higher BMI and total fat percentage at both
time points but without a significant change over time. To our
knowledge, the childhood cancer survivor study (CCSS) is the
only study to date that describes longitudinal changes in
childhood cancer survivors at very long-term follow-up [19].
In this study, self-reported BMI was evaluated in ALL survivors
25 years after diagnosis, and CRT was defined as a risk factor
for BMI change, particularly in women [19]. Brouwer et al.
Table 2. Total fat percentage, BMI and waist-hip ratio for adult survivors of childhood cancer.
Body Mass Index Waist-hip Ratio*
Men N=235
Women
N=172 Total N=407 Men N=174
Women
N=125 Total N=299
Concordant
BMI/WHR non obese, total fat % non-obese 120 (51) 39 (23) 159 (39) 80 (46) 29 (23) 109 (37)
BMI/WHR obese, total fat % obese 17 (7) 21 (12) 38 (9) 40 (23) 41 (33) 81 (27)
Discordant
BMI/WHR non-obese, total fat % obese 98 (42) 112 (65) 210 (52) 42 (24) 50 (40) 92 (31)
BMI/WHR obese, total fat % non-obese 0 0 0 12 (7) 5 (4) 17 (6)
*Survivors treated with abdominal radiotherapy were excluded.
doi:10.1371/journal.pone.0043269.t002
Figure 3. BMI versus total fat percentage. Female and male survivors in the upper quadrant corner, marked by the red respectively the blue
horizontal line and black vertical line, are classified as non-obese by BMI, but as obese by total fat percentage.
doi:10.1371/journal.pone.0043269.g003
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showed that BMI increased in Dutch childhood cancer
survivors, from the end of treatment until attainment of final
height and observed that high dose CRT was the most
important risk factor for this BMI increase [31]. Long after
attainment of final height, all of our male survivors showed a
higher BMI increase compared with the reference population,
suggesting that cancer treatment effects persist over time. This
BMI increase did not result in a significantly higher BMI
3 years later. However, taking into account the short time-
interval, this significant increase in BMI at a relatively young
age might indicate an emerging problem in the future. In
female survivors BMI was significantly higher after CRT
treatment; however, there was no significant change over time,
suggesting that changes in BMI had already occurred at a
younger age. Furthermore, the interval between measurements
was only 3 years and survivors had a younger age at the 1st
assessment (median 24 years) as compared with the CCSS
(median 32 years) which might explain the different findings.
Additionally, since annual reference data from the CBS are self-
reported, BMI could be underestimated, possibly affecting the
comparison between BMI in survivors and controls in this
study.
Previous studies have been mainly based on self-reported or
measured BMI values. Recently it was shown that BMI is an
inaccurate marker for total body fat. Obesity was underesti-
mated in 39% of subjects, using BMI [10]. Therefore, we used
DXA to assess total fat percentage and lean body mass, which
are considered to be more relevant predictors for cardiovascular
disease or diabetes mellitus [6,7,8,9]. In the current study, total
fat percentage was persistently and significantly higher than the
reference population and was more pronounced in CRT
survivors. Furthermore, while mean BMI standard deviation
scores varied around zero, increases in total fat percentage SDS
and decreases in lean body mass SDS were more pronounced.
This implies that although BMI may seem normal, the
distribution of total fat and lean body mass might be
dramatically changed. Therefore, in order to test the hypothesis
that BMI underestimates the adiposity risk in childhood cancer
survivors, BMI data were compared with total fat percentage of
all the survivors in whom one DXA scan was performed. This
revealed that indeed 42% of male survivors and 65% of female
survivors were classified as non-obese by BMI, but as obese by
total fat percentage. These percentages of misclassification are
even greater than compared with earlier findings in the general
population by Shah and Braverman, although our subjects were
much younger [10]. This finding emphasizes the need for more
precise measurements of total fat percentage in order to define
obesity. Since DXA is costly and not easily accessible for less
developed countries, we attempted to define more accurate cut-
off limits for BMI in childhood cancer survivors. It was shown
that a cut-off limit of 24 for males and 22 for females resulted
in greater sensitivity, with only small reductions in specificity.
Although the group was too small to draw definite conclusions,
these findings indicate that the current cut-off of 30 is not useful
in defining obesity in childhood cancer survivors. A more
reliable determinant than BMI that predicts the development of
cardiovascular disease is the amount of intra-abdominal fat,
which is approximated by the waist-hip ratio [11,12]. Above all,
waist-hip ratio is an easy to use clinical tool. However, when we
compared waist-hip ratio with total fat percentage in childhood
cancer survivors, percentage misclassification was lower than
with BMI, but still 31%.
Mechanisms that contribute to abnormal body composition in
childhood cancer survivors include decrease in physical activity,
hypothalamic-, pituitary and/or gonadal damage, due to cranial
and abdominal radiotherapy and leading to endocrinopathies and
use of corticosteroids, followed by metabolic changes
[5,11,12,13,14,15].
Limitations
In the current retrospective study no data concerning socio-
economic status, smoking, diet and physical activity for the total
cohort of survivors, which could be important predictors for
BMI change, were available. Reduced energy expenditure and
excess energy intake may play a role in the development of
overweight in childhood cancer survivors, and has been
described during and shortly after treatment [32,33]. Further-
more, since obesity is not an independent risk factor for
Table 3. Sensitivity and specificity for different cut-off points
of BMI and waist-hip ratio as defined by total fat percentage
of $25% for men and $30% for women.
Male Female
Sensitivity Specificity Sensitivity Specificity
BMI cut-off point
18 100 4 99 10
20 98 25 92 54
22 91 58 80 82
24 72 76 53 97
26 47 95 32 97
28 28 98 23 97
30* 14 100 16 100
32 6 100 11 100
WHR cut-off point
0.77 98 3 93 9
0.78 98 8 89 21
0.79 98 9 84 32
0.80 96 12 80 50
0.81 94 15 75 59
0.82 91 22 71 71
0.83 88 34 60 76
0.84 86 42 54 82
0.85* 81 48 45 85
0.86 73 56 42 88
0.87 63 70 33 88
0.88 59 76 31 91
0.89 54 85 24 94
0.90* 49 87 20 97
0.91 42 88 13 97
0.92 40 91 12 97
0.93 33 95 9 100
0.94 28 96 n.a. n.a.
0.95 28 97 n.a. n.a.
0.96 22 97 n.a. n.a.
0.97 19 98 n.a. n.a.
0.98 17 99 n.a. n.a.
*Cut-off limits of BMI respectively waist-hip ratio generally used for the
classification of obesity.
doi:10.1371/journal.pone.0043269.t003
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cardiovascular morbidity, prospective studies are needed,
investigating multiple risk factors such as hypertension, dyslipi-
demia, insulin resistance and life style changes in very long-term
survivors of childhood cancer.
Conclusion
In this large and unique longitudinal study among childhood
cancer survivors, a greater increase in BMI and total fat
percentage compared with the reference population was found,
especially in adult male survivors,. Furthermore, we found that
BMI underestimated obesity by 52% of adult survivors, while
waist-hip ratio underestimated 31% of survivors when compared
with measurements of total fat percentage. Therefore, we have
suggested new cut-off limits, which need to be confirmed in future
prospective studies, in order to define obesity more precisely in
childhood cancer survivors.
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